Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kalhs

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Haematology|October 26, 1999
The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patientsP Stohlawetz, A Schulenburg, G Stiegler, et al.
Bone Marrow Transplantation|November 5, 2003
Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorptionW Rabitsch, P Knöbl, E Prinz, et al.
Bone Marrow Transplantation|January 1, 1991
Fertility, pregnancies and offspring complications after bone marrow transplantationM Hinterberger-Fischer, P Kier, P Kalhs, et al.
Leukemia|February 13, 2002
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantationA Becherer, M Mitterbauer, U Jaeger, et al.
Bone Marrow Transplantation|May 1, 1992
Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host diseaseP Valent, K C Sillaber, R Scherrer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic featuresH Kaufmann, J Ackermann, H Greinix, et al.
Bone Marrow Transplantation|January 27, 2009
KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantationK Ludajic, Y Balavarca, H Bickeböller, et al.
Intensive Care Medicine|January 1, 1997
Plasma exchange for treatment of thrombotic thrombocytopenic purpura in critically ill patientsP Knöbl, C Rintelen, G Kornek, et al.
Transplantation|November 15, 1995
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxisP Kalhs, S Brugger, I Schwarzinger, et al.
Bone Marrow Transplantation|September 1, 1994
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humansM Hinterberger-Fischer, P Kier, J Spona, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Haematology|October 26, 1999
The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patientsP Stohlawetz, A Schulenburg, G Stiegler, et al.
Bone Marrow Transplantation|November 5, 2003
Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorptionW Rabitsch, P Knöbl, E Prinz, et al.
Bone Marrow Transplantation|January 1, 1991
Fertility, pregnancies and offspring complications after bone marrow transplantationM Hinterberger-Fischer, P Kier, P Kalhs, et al.
Leukemia|February 13, 2002
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantationA Becherer, M Mitterbauer, U Jaeger, et al.
Bone Marrow Transplantation|May 1, 1992
Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host diseaseP Valent, K C Sillaber, R Scherrer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic featuresH Kaufmann, J Ackermann, H Greinix, et al.
Bone Marrow Transplantation|January 27, 2009
KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantationK Ludajic, Y Balavarca, H Bickeböller, et al.
Intensive Care Medicine|January 1, 1997
Plasma exchange for treatment of thrombotic thrombocytopenic purpura in critically ill patientsP Knöbl, C Rintelen, G Kornek, et al.
Transplantation|November 15, 1995
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxisP Kalhs, S Brugger, I Schwarzinger, et al.
Bone Marrow Transplantation|September 1, 1994
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humansM Hinterberger-Fischer, P Kier, J Spona, et al.
Pageof 10